Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€3.16

€3.16

-2.020%
-0.065
-2.020%
-

-

 
26.11.21 / Frankfurt WKN: A1W7Q9 / Name: Celyad / Stock / Biotechnology & Medical Research / Small Cap /

Cardio3 Biosciences S.A. Stock

A loss of -2.020% shows a downward development for Cardio3 Biosciences S.A..

Pros and Cons of Cardio3 Biosciences S.A. in the next few years

Pros
?
Shareholder structure
?
Conscious of the environment
?
Growth compared to competition
Cons
?
Worthwhile Investment for the next years
?
Brand
?
Market Position
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Cardio3 Biosciences S.A. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Cardio3 Biosciences S.A. -2.020% -9.456% -24.941% -59.226% -50.779% -86.079% -82.855%
Mdxhealth -3.520% -7.006% -23.493% -2.232% 2.576% - -
Oxurion NV 0.310% -3.882% -7.078% -28.743% -24.624% -51.039% -26.742%
Intellia Therapeutics Inc -0.540% -13.554% -12.909% 229.591% 120.484% 558.090% 513.919%

Other discussions about Cardio3 Biosciences S.A. Stock

New thread Forum